TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MDT

Medtronic PLC

Healthcare · Medical Devices

91.80$ -0.4% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios MDT
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Valuation
30.9 31.9 28.7 35.3 26.0 27.5 49.2 28.0 32.3 29.0 23.5 21.7
4.1 3.9 3.9 3.7 3.9 4.6 5.9 4.5 3.9 3.3 3.3 2.9
1.6 2.2 2.3 2.2 2.4 2.6 3.4 2.7 2.4 2.1 2.3 2.1
5.6 4.9 4.8 4.4 4.6 5.3 6.6 5.1 4.6 4.0 4.0 3.6
20.9 16.6 16.7 13.9 15.2 19.5 26.6 18.4 16.6 15.9 14.7 13.3
19.1 27.1 20.6 30.3 20.5 21.9 36.3 23.6 26.5 20.5 21.1 19.2
5.2% 3.7% 4.9% 3.3% 4.9% 4.6% 2.8% 4.2% 3.8% 4.9% 4.7% 5.2%
Margins
68.9% 68.3% 68.7% 69.7% 70.0% 67.4% 65.2% 68.0% 65.7% 65.3% 65.3% 65.0%
18.6% 18.6% 18.1% 22.2% 20.5% 16.6% 14.9% 18.2% 17.6% 15.9% 17.8% 17.8%
13.2% 12.3% 13.6% 10.4% 15.2% 16.6% 12.0% 15.9% 12.0% 11.4% 13.9% 13.2%
21.4% 14.5% 18.9% 12.1% 19.2% 20.8% 16.2% 18.9% 14.7% 16.1% 15.5% 14.9%
Returns
5.0% 6.8% 8.0% 6.1% 9.2% 9.4% 7.0% 9.6% 7.3% 7.3% 9.7% 9.7%
2.5% 3.6% 4.0% 3.4% 5.2% 5.3% 3.9% 5.5% 4.1% 4.1% 5.1% 5.2%
Balance Sheet & Debt
31,301 28,444 28,456 22,072 20,921 20,612 22,796 20,400 22,821 23,685 26,246 25,958
5.7 3.3 3.3 2.3 2.2 2.6 3.0 2.3 2.6 2.9 2.8 2.6
49.9% 52.1% 50.4% 55.5% 55.8% 55.9% 55.2% 57.8% 56.6% 55.8% 52.4% 53.2%
0.7 0.6 0.7 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.6
Per Share
2.41 2.48 2.89 2.27 3.41 3.54 2.66 3.73 2.82 2.76 3.61 3.73
18.27 20.22 21.35 21.89 22.51 21.40 22.24 23.45 23.43 24.33 26.00 28.23
48.00 36.35 36.15 37.07 36.90 37.55 37.98 38.89 38.63 37.75 37.23 38.40
3.91 2.93 4.04 2.64 4.33 4.46 3.61 4.42 3.44 3.91 4.02 4.21

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?